Abstract |
Pituitary tumor transforming gene 1 (PTTG1), a transforming gene highly expressed in several cancers, is a mammalian securin protein regulating both G1/S and G2/M phases. Using protein array screening, we showed PTTG1 interacting with Aurora kinase A (Aurora-A), and confirmed the interaction using co-immunoprecipitation, His-tagged pull-down assays and intracellular immunofluorescence colocalization. PTTG1 transfection into HCT116 cells prevented Aurora-A T288 autophosphorylation, inhibited phosphorylation of the histone H3 Aurora-A substrate and resulted in abnormally condensed chromatin. PTTG1-null cell proliferation was more sensitive to Aurora-A knock down and to Aurora kinase Inhibitor III treatment. The results indicate that PTTG1 and Aurora-A interact to regulate cellular responses to anti-neoplastic drugs. PTTG1 knockdown is therefore a potential approach to improve the efficacy of tumor Aurora kinase inhibitors.
|
Authors | Y Tong, A Ben-Shlomo, C Zhou, K Wawrowsky, S Melmed |
Journal | Oncogene
(Oncogene)
Vol. 27
Issue 49
Pg. 6385-95
(Oct 23 2008)
ISSN: 1476-5594 [Electronic] England |
PMID | 18663361
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Neoplasm Proteins
- Securin
- pituitary tumor-transforming protein 1, human
- AURKA protein, human
- Aurora Kinase A
- Aurora Kinases
- Protein Serine-Threonine Kinases
|
Topics |
- Aurora Kinase A
- Aurora Kinases
- Cell Line, Tumor
- Gene Expression Regulation, Neoplastic
- HCT116 Cells
- Humans
- Neoplasm Proteins
(genetics)
- Protein Serine-Threonine Kinases
(analysis, genetics, metabolism)
- Securin
- Transfection
|